JANE STREET GROUP, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 83 filers reported holding RELMADA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$29,810
-92.8%
12,118
-89.8%
0.00%
Q4 2022$413,855
+76.9%
118,583
+860.3%
0.00%
Q2 2022$234,000
-90.4%
12,348
-86.3%
0.00%
Q1 2022$2,439,000
+86.6%
90,343
+121.3%
0.00%
Q2 2021$1,307,000
+43.9%
40,819
+44.2%
0.00%
Q4 2020$908,000
-68.1%
28,300
-55.5%
0.00%
-100.0%
Q2 2020$2,845,000
+949.8%
63,598
+701.4%
0.00%
Q1 2020$271,0007,9360.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders